Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment

The study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups. For 60 days, Group I received mildronate, 1.0 g/d, Group II - preductal MV (trimetazidin...

Full description

Bibliographic Details
Main Authors: G. G. Semenkova, L. V. Kokoreva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2007-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2082